ロード中...
CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults
Atopic dermatitis (AD) is a condition frequently encountered in medical practices across the country. Arming ourselves with appropriate and safe treatment modalities to provide relief for this chronic and relapsing inflammatory condition is of utmost importance to our patients and their families. Ut...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3707742/ https://ncbi.nlm.nih.gov/pubmed/23837743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-9-24 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|